Brii Biosciences Ltd. sell Ruckelsbuckel
Start price
08.01.22
/
80%
€3.10
Target price
08.01.23
€2.00
Performance (%)
-37.74%
End price
28.01.22
€1.93
Summary
This prediction ended on 28.01.22 with a price of €1.93. Ruckelsbuckel correctly predicted massive losses of -37.74% for Brii Biosciences Ltd.. Ruckelsbuckel has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Brii Biosciences Ltd. | 5.833% | 5.833% | -72.979% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to Ruckelsbuckel what are the pros and cons of Brii Biosciences Ltd. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Fair valuation
High Investments for future growth
Very valuable balance sheet
Small challenges to pay loans and raise capital
ROE higher than 15% per year
Very capable Management
Very good company culture
Leading role in innovation
Strong uniques
Very differentiated customer and product portfolio
Sustainability is important
Management is a major shareholder
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Cons
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Growths slower than the competition
Higher risks for its business
Significant cyclical dependencies
Comments by Ruckelsbuckel for this prediction
In the thread Brii Biosciences Ltd. diskutieren
Sell mit Kursziel 2,0